AKT1 and breast cancer: In another report, the phosphatidylinositol 3-kinase (PI3K) inhibitor drug was conjugated with Au nanorod (NR) to investigate its ability to inhibit the PI3K/Akt Pathway and related pathways in breast cancer cell lines.